                         SEQUENCE LISTING

<110>  OPKO Diagnostics, LLC
 
<120>  COMPOSITIONS AND METHODS RELATED TO DIAGNOSIS OF PROSTATE CANCER

<130>  C1256.70013WO00

<150>  US 61/972,099
<151>  2014-03-28

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  1

Glu Val Gln Leu Val Glu Ser Gly Pro Gly Ile Leu Gln Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ser Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Gly Met Gly Val Ser Trp Ile Arg Gln Pro Ser Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Leu Ala His Leu Tyr Trp Asp Glu Asp Lys Arg Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Glu Asp Ser Ser Arg Asn Gln Val 
65                  70                  75                  80  


Phe Leu Lys Ile Thr Ser Val Gly Pro Ala Asp Ser Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Lys Gly Tyr Tyr Gly Tyr Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Ala Leu Thr Val Ser Ser 
        115                 


<210>  2
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  2

Asp Ile Val Met Thr Gln Ser Gln Lys Phe Met Ser Thr Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Ser Val Thr Cys Lys Ala Ser Gln Asn Val Asn Thr Asp 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Lys Ala Leu Ile 
        35                  40                  45              


Phe Ser Thr Ser Tyr Arg Ser Ser Gly Val Pro Asp Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Asn Val Gln Ser 
65                  70                  75                  80  


Glu Asp Leu Ala Glu Tyr Phe Cys Gln Gln Tyr Ser Asn Tyr Pro Leu 
                85                  90                  95      


Thr Phe Gly Ala Gly Thr Lys Val Asp Leu Asn 
            100                 105         


<210>  3
<211>  237
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  3

Ile Val Gly Gly Trp Glu Cys Glu Lys His Ser Gln Pro Trp Gln Val 
1               5                   10                  15      


Leu Val Ala Ser Arg Gly Arg Ala Val Cys Gly Gly Val Leu Val His 
            20                  25                  30          


Pro Gln Trp Val Leu Thr Ala Ala His Cys Ile Arg Asn Lys Ser Val 
        35                  40                  45              


Ile Leu Leu Gly Arg His Ser Leu Phe His Pro Glu Asp Thr Gly Gln 
    50                  55                  60                  


Val Phe Gln Val Ser His Ser Phe Pro His Pro Leu Tyr Asp Met Ser 
65                  70                  75                  80  


Leu Leu Lys Asn Arg Phe Leu Arg Pro Gly Asp Asp Ser Ser His Asp 
                85                  90                  95      


Leu Met Leu Leu Arg Leu Ser Glu Pro Ala Glu Leu Thr Asp Ala Val 
            100                 105                 110         


Lys Val Met Asp Leu Pro Thr Gln Glu Pro Ala Leu Gly Thr Thr Cys 
        115                 120                 125             


Tyr Ala Ser Gly Trp Gly Ser Ile Glu Pro Glu Glu Phe Leu Thr Pro 
    130                 135                 140                 


Lys Lys Leu Gln Cys Val Asp Leu His Val Ile Ser Asn Asp Val Cys 
145                 150                 155                 160 


Ala Gln Val His Pro Gln Lys Val Thr Lys Phe Met Leu Cys Ala Gly 
                165                 170                 175     


Arg Trp Thr Gly Gly Lys Ser Thr Cys Ser Gly Asp Ser Gly Gly Pro 
            180                 185                 190         


Leu Val Cys Asn Gly Val Leu Gln Gly Ile Thr Ser Trp Gly Ser Glu 
        195                 200                 205             


Pro Cys Ala Leu Pro Glu Arg Pro Ser Leu Tyr Thr Lys Val Val His 
    210                 215                 220                 


Tyr Arg Lys Trp Ile Lys Asp Thr Ile Val Ala Asn Pro 
225                 230                 235         


<210>  4
<211>  237
<212>  PRT
<213>  Homo sapiens

<400>  4

Ile Val Gly Gly Trp Glu Cys Glu Lys His Ser Gln Pro Trp Gln Val 
1               5                   10                  15      


Ala Val Tyr Ser His Gly Trp Ala His Cys Gly Gly Val Leu Val His 
            20                  25                  30          


Pro Gln Trp Val Leu Thr Ala Ala His Cys Leu Lys Lys Asn Ser Gln 
        35                  40                  45              


Val Trp Leu Gly Arg His Asn Leu Phe Glu Pro Glu Asp Thr Gly Gln 
    50                  55                  60                  


Arg Val Pro Val Ser His Ser Phe Pro His Pro Leu Tyr Asn Met Ser 
65                  70                  75                  80  


Leu Leu Lys His Gln Ser Leu Arg Pro Asp Glu Asp Ser Ser His Asp 
                85                  90                  95      


Leu Met Leu Leu Arg Leu Ser Glu Pro Ala Lys Ile Thr Asp Val Val 
            100                 105                 110         


Lys Val Leu Gly Leu Pro Thr Gln Glu Pro Ala Leu Gly Thr Thr Cys 
        115                 120                 125             


Tyr Ala Ser Gly Trp Gly Ser Ile Glu Pro Glu Glu Phe Leu Arg Pro 
    130                 135                 140                 


Arg Ser Leu Gln Cys Val Ser Leu His Leu Leu Ser Asn Asp Met Cys 
145                 150                 155                 160 


Ala Arg Ala Tyr Ser Glu Lys Val Thr Glu Phe Met Leu Cys Ala Gly 
                165                 170                 175     


Leu Trp Thr Gly Gly Lys Asp Thr Cys Gly Gly Asp Ser Gly Gly Pro 
            180                 185                 190         


Leu Val Cys Asn Gly Val Leu Gln Gly Ile Thr Ser Trp Gly Pro Glu 
        195                 200                 205             


Pro Cys Ala Leu Pro Glu Lys Pro Ala Val Tyr Thr Lys Val Val His 
    210                 215                 220                 


Tyr Arg Lys Trp Ile Lys Asp Thr Ile Ala Ala Asn Pro 
225                 230                 235         


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  5

Ser Cys Pro His His His His His His 
1               5                   


